Global Point of Care
Royal Derby Hospital has been leading the way in infection control through point of care testing (POCT) since 2018. The hospital recognises the importance of POCT not just for patient safety, but also for staff in a medical environment.
In 2021, Royal Derby Hospital's paediatric team implemented POCT for the respiratory syncytial virus (RSV) in the emergency department. As a result of year-round RSV testing, the department discovered an unexpected surge in summer cases.
Yusuf Gray is Advanced Biomedical Scientist, Point of Care Technologies, University Hospitals Derby & Burton NHS Foundation Trust. He says: “The summer surge in RSV cases was surprising to see as RSV is predominately considered a winter illness, along with flu. Regular testing for these illnesses usually ends as we come out of the winter months.”
This increase in testing resulted in better care for patients, as Yusuf Gray explains, “by continuing to test people that came through the Paediatric or the Emergency Department we were more quickly able to diagnose those with RSV and get them access to antiviral medication if needed.”
Data from hospital testing showed that in January 2022
just 5.5% of symptomatic patients tested positive for RSV.
By July 2022 the figures had increased to 40%.
Data from hospital testing showed that in January 2022
just 5.5% of symptomatic patients tested positive for RSV.
By July 2022 the figures had increased to 40%.
A Leader In Rapid Point-of-care Diagnostics.
©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.